{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:14:18Z","timestamp":1777497258138,"version":"3.51.4"},"reference-count":122,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CH"],"published-print":{"date-parts":[[2022,9,20]]},"abstract":"<jats:p>In a cohort of subjects with asymptomatic carotid atherosclerosis (ACA), we have evaluated the neutrophil and lymphocyte count and their ratio (NLR), the gelatinases (MMP-2 and MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2). At baseline, no difference was observed between ACA subjects and subject control group regarding neutrophil and lymphocyte count while was evident in ACA subjects a significant increase in MMP-2, MMP-9 and TIMP-2 associated to a significant decrease in TIMP-1. Dividing the ACA according to the number of cardiovascular risk factors (CRFs) we have observed an increase in lymphocyte count in the subgroup with 3\u20135 CRFs. Evaluating the leukocyte subtypes according to all the surrogate markers of insulin resistance has been noted, in the subgroups that exceed the medians of these markers, a significant increase in neutrophil and lymphocyte count without any variation of the NLR. Effecting the same evaluation for the MMP\/TIMP pattern we observed, instead, that the same subgroups tend to show a decrease in MMP-2 and an increase in MMP-9. No difference instead for TIMP-1 and TIMP-2. The abnormality of the MMP\/TIMP pattern, bearing in mind the cardiometabolic clustering present in this cohort of ACA subjects, would induce to use drugs able not only to cure the cardiometabolic risk factors but also to influence the MMP\/TIMP profile.<\/jats:p>","DOI":"10.3233\/ch-221380","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T11:45:30Z","timestamp":1653047130000},"page":"37-51","source":"Crossref","is-referenced-by-count":3,"title":["Leukocyte subtypes, gelatinases, and their tissue inhibitors in a group of subjects with asymptomatic carotid atherosclerosis"],"prefix":"10.1177","volume":"82","author":[{"given":"Gregorio","family":"Caimi","sequence":"first","affiliation":[{"name":"Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Universit\u00e0 degli Studi di Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Urso","sequence":"additional","affiliation":[{"name":"Fondazione Istituto \u201cG. Giglio\u201d Cefal\u00f9, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brucculeri","sequence":"additional","affiliation":[{"name":"Fondazione Istituto \u201cG. Giglio\u201d Cefal\u00f9, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Amato","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Universit\u00e0 degli Studi di Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lo Presti","sequence":"additional","affiliation":[{"name":"Department of Psychology, Educational Science and Human Movement, Universit\u00e0 degli Studi di Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carlisi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Universit\u00e0 degli Studi di Palermo, Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CH-221380_ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(03)00164-3","article-title":"Leukocytes and coronary heart disease","volume":"172","author":"Hoffman","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.3233\/CH-221380_ref2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/euhj.1999.1699","article-title":"Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease","volume":"21","author":"Danesh","year":"2000","journal-title":"Eur Heart J"},{"key":"10.3233\/CH-221380_ref3","first-page":"17","article-title":"Components of the complete blood count as risk predictors for coronary heart disease: In-depth review and update","volume":"40","author":"Madjid","year":"2013","journal-title":"Tex Heart Inst J"},{"key":"10.3233\/CH-221380_ref4","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1038\/s41598-018-21661-x","article-title":"Elements of the complete blood count associated with cardiovascular disease incidence: Findings from the EPIC-NL cohort study","volume":"8","author":"Lassale","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/CH-221380_ref5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ehj.2004.05.002","article-title":"Associations between differential leucocyte count and incident coronary heart disease: incident cases from seven prospective studies of 30.374 individuals","volume":"25","author":"Wheeler","year":"2004","journal-title":"Eur Heart J"},{"key":"10.3233\/CH-221380_ref6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/VHRM.S2240","article-title":"Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population","volume":"4","author":"Waterhouse","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.3233\/CH-221380_ref7","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.2174\/092986711796391633","article-title":"Low lymphocyte count and cardiovascular diseases","volume":"18","author":"N\u00fa\u00f1ez","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.3233\/CH-221380_ref8","first-page":"591","article-title":"Neutrophils and clinical outcomes in patients with acute coronary syndromes and\/or cardiac revascularisation","volume":"106","author":"Guasti","year":"2011","journal-title":"A systematic review on more than 34,000 subjects. Thromb Haemost"},{"key":"10.3233\/CH-221380_ref9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2007.11.004","article-title":"Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction","volume":"101","author":"N\u00fa\u00f1ez","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.3233\/CH-221380_ref10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0002-9149(96)00878-8","article-title":"Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease","volume":"79","author":"Ommen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.3233\/CH-221380_ref11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2009.01.029","article-title":"Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels","volume":"206","author":"N\u00fa\u00f1ez","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.3233\/CH-221380_ref12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.amjcard.2003.11.013","article-title":"Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction","volume":"93","author":"Kirtane","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.3233\/CH-221380_ref13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.annepidem.2004.08.009","article-title":"Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: The NHANES-I epidemiologic follow-up study","volume":"15","author":"Gillum","year":"2005","journal-title":"Ann Epidemiol"},{"key":"10.3233\/CH-221380_ref14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.archger.2015.03.011","article-title":"Neutrophil-lymphocyte ratio is associated with arterial stiffness in postmenopausal women with osteoporosis","volume":"61","author":"Yu","year":"2015","journal-title":"Arch Gerontol Geriatr"},{"key":"10.3233\/CH-221380_ref15","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","article-title":"Intermountain Heart Collaborative Study Group: Which white blood cell subtypes predict increased cardiovascular risk?","volume":"45","author":"Horne","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.3233\/CH-221380_ref16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.atherosclerosis.2006.11.022","article-title":"Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction","volume":"196","author":"Dragu","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.3233\/CH-221380_ref17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1586\/14779072.2014.902309","article-title":"Neutrophil-lymphocyte ratio as an important assessment tool","volume":"12","author":"Balta","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.3233\/CH-221380_ref18","doi-asserted-by":"crossref","first-page":"1989417","DOI":"10.1155\/2017\/1989417","article-title":"The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic Korean males: A cross-sectional study","volume":"2017","author":"Nam","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.3233\/CH-221380_ref19","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/01.CIR.84.4.1758","article-title":"Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia\/reperfusion","volume":"84","author":"Kloner","year":"1991","journal-title":"Circulation"},{"key":"10.3233\/CH-221380_ref20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jch.13002","article-title":"The relationship between neutrophil to lymphocyte ratio and artery stiffness in subtypes of hypertension","volume":"19","author":"Wang","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.3233\/CH-221380_ref21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cca.2011.01.021","article-title":"Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score","volume":"412","author":"Park","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.3233\/CH-221380_ref22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/erc.12.159","article-title":"Neutrophil to lymphocyte ratio and cardiovascular diseases: A review","volume":"11","author":"Bhat","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.3233\/CH-221380_ref23","first-page":"912","article-title":"Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio","volume":"20","author":"Yaman","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.3233\/CH-221380_ref24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/1076029613507337","article-title":"White blood cell subtypes and neutrophil-lymphocyte ratio in prediction of coronary thrombus formation in non-ST-segment elevated acute coronary syndrome","volume":"21","author":"Yilmaz","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.3233\/CH-221380_ref25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5603\/CJ.a2013.0148","article-title":"Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction","volume":"21","author":"Sawant","year":"2014","journal-title":"Cardiol J"},{"key":"10.3233\/CH-221380_ref26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"key":"10.3233\/CH-221380_ref27","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.07.024","article-title":"Can the neutrophil-to-lymphocyte ratio appropriately predict carotid artery stenosis in patients with ischemic stroke? A retrospective study","volume":"11","author":"Hyun","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.3233\/CH-221380_ref28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.01.002","article-title":"Neutrophil-to-lymphocyte ratio correlates with severity of extracranial carotid stenosis-a study using digital subtraction angiography","volume":"26","author":"Jiang","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.3233\/CH-221380_ref29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.031","article-title":"Is Elevated Neutrophil-to-Lymphocyte Ratio a Predictor of Stroke in Patients with Intermediate Carotid Artery Stenosis?","volume":"25","author":"K\u00f6kl\u00fc","year":"2016","journal-title":"J Stroke Cerebrovas Dis"},{"key":"10.3233\/CH-221380_ref30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4250\/jcu.2016.24.2.115","article-title":"The combined impact of neutrophil-to-lymphocyte ratio and type 2 diabetic mellitus on significant coronary artery disease and carotid artery atherosclerosis","volume":"24","author":"Kim","year":"2016","journal-title":"J Cardiovasc Ultrasound"},{"key":"10.3233\/CH-221380_ref31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4250\/jcu.2016.24.2.104","article-title":"Neutrophil-to-lymphocyte ratio for risk assessment in coronary artery disease and carotid artery atherosclerosis","volume":"24","author":"Park","year":"2016","journal-title":"J Cardiovasc Ultrasound"},{"key":"10.3233\/CH-221380_ref32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4070\/kcj.2016.46.5.699","article-title":"Association of neutrophil\/lymphocyte ratio with plaque morphology in patients with asymptomatic intermediate carotid artery stenosis","volume":"46","author":"Y\u00fcksel","year":"2016","journal-title":"Korean Circ J."},{"key":"10.3233\/CH-221380_ref33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1076029615569568","article-title":"The relation between atherosclerosis and the neutrophil-lymphocyte ratio","volume":"22","author":"Balta","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.3233\/CH-221380_ref34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2012.09.009","article-title":"Neutrophil\/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography","volume":"225","author":"Arbel","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.3233\/CH-221380_ref35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0003319711412763","article-title":"Hematologic parameters and angiographic progression of coronary atherosclerosis","volume":"63","author":"Kalay","year":"2012","journal-title":"Angiology"},{"key":"10.3233\/CH-221380_ref36","first-page":"397","article-title":"The neutrophil\u2013lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects","volume":"36","author":"Urbistondo","year":"2016","journal-title":"Nefrologia"},{"key":"10.3233\/CH-221380_ref37","first-page":"215","article-title":"Matrix metalloproteinases involvement in pathologic conditions","volume":"51","author":"Am\u0103linei","year":"2010","journal-title":"Rom J Morphol Embryol"},{"key":"10.3233\/CH-221380_ref38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.resp.2010.08.019","article-title":"Redox-control of Matrix Metalloproteinase- A critical link between free radicals, matrix remodeling and degenerative disease","volume":"174","author":"Kar","year":"2010","journal-title":"Respir Physiol Neurobiol"},{"key":"10.3233\/CH-221380_ref39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","article-title":"Physiology and pathophysiology of matrix metalloproteases","volume":"41","author":"Klein","year":"2011","journal-title":"Amino Acids"},{"key":"10.3233\/CH-221380_ref40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijcard.2012.10.040","article-title":"C-reactive protein induces expression of matrix metalloproteinase- A possible link between inflammation and plaque rupture","volume":"168","author":"Cimmino","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.3233\/CH-221380_ref41","first-page":"323","article-title":"Biology of metalloproteinases","volume":"48","author":"Am\u0103linei","year":"2007","journal-title":"Rom J Morphol Embryol"},{"key":"10.3233\/CH-221380_ref42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(03)00140-0","article-title":"High glucose alters matrix metalloproteinase expression in two key vascular cells: Potential impact on atherosclerosis in diabetes","volume":"168","author":"Death","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.3233\/CH-221380_ref43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.25011\/cim.v32i2.6030","article-title":"Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia","volume":"32","author":"Derosa","year":"2009","journal-title":"Clin Invest Med"},{"key":"10.3233\/CH-221380_ref44","doi-asserted-by":"crossref","unstructured":"Papazoglou D , Papaytheodorou K , Papanas N , Papadopoulos T , Gioka T , Kabouromiti G , et al. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 levels in severely obese patients: What is the effect of weight loss? Exp Clin Endocrinol Diab 2010;118:730\u2013734.","DOI":"10.1055\/s-0030-1249671"},{"key":"10.3233\/CH-221380_ref45","first-page":"779","article-title":"Abnormal circulating levels of matrix metalloproteinases and their inhibitors in diabetes mellitus","volume":"58","author":"Zayani","year":"2012","journal-title":"Clin Lab"},{"key":"10.3233\/CH-221380_ref46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cca.2011.12.021","article-title":"Circulating matrix metalloproteinases and their inhibitors in hypertension","volume":"413","author":"Fontana","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.3233\/CH-221380_ref47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1465-9921-15-74","article-title":"FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure","volume":"15","author":"Montano","year":"2014","journal-title":"Respir Res"},{"key":"10.3233\/CH-221380_ref48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7754\/Clin.Lab.2015.150633","article-title":"Abnormal circulating levels of metalloproteinase and their inhibitor in hypertensive patients","volume":"62","author":"Zayani","year":"2016","journal-title":"Clin Lab"},{"key":"10.3233\/CH-221380_ref49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cyto.2016.07.009","article-title":"Inflammations mediators and circulating levels of matrix metalloproteinases: Biomarkers of diabetes in Tunisians metabolic syndrome patients","volume":"86","author":"Zayani","year":"2016","journal-title":"Cytokine."},{"key":"10.3233\/CH-221380_ref50","first-page":"1015","article-title":"The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome","volume":"20","author":"Erman","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.3233\/CH-221380_ref51","first-page":"198","article-title":"MMP-9 levels and IMT of carotid arteries are elevated in obese children and adolescents compared to non-obese","volume":"108","author":"Andrade","year":"2017","journal-title":"Arq Bras Cardiol"},{"key":"10.3233\/CH-221380_ref52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.jhh.1002244","article-title":"Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension","volume":"21","author":"Zhou","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.3233\/CH-221380_ref53","first-page":"3160","article-title":"Quantitative ultrasonic integrated backscatter of the intima-media complex, serum level of matrix metalloproteinase-9 and simvastatin in hyperlipemia patients","author":"Zhang","year":"2008","journal-title":"Zhong Nan Da Ban"},{"key":"10.3233\/CH-221380_ref54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejim.2008.10.003","article-title":"Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment","volume":"20","author":"Onal","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.3233\/CH-221380_ref55","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/ATVBAHA.110.208462","article-title":"Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality","volume":"30","author":"Velagaleti","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/CH-221380_ref56","doi-asserted-by":"crossref","first-page":"e16185","DOI":"10.1371\/journal.pone.0016185","article-title":"Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: Cohort study","volume":"6","author":"Hansson","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/CH-221380_ref57","doi-asserted-by":"crossref","first-page":"3872367","DOI":"10.1155\/2020\/3872367","article-title":"The role of matrix metalloproteinase-9 in atherosclerotic plaque instability","volume":"2020","author":"Li","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.3233\/CH-221380_ref58","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.3390\/ijms21113946","article-title":"Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability","volume":"21","author":"Olejarz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/CH-221380_ref59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11010-012-1306-y","article-title":"Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes-macrophages by enhanced production of ROS, TNF-\u03b1, MMP-9 and MMP-2","volume":"366","author":"Soumyarani","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"10.3233\/CH-221380_ref60","first-page":"5253","article-title":"Carotid thickness and atherosclerotic plaque stability, serum inflammation, serum MMP-2 and MMP-9 were associated with acute cerebral infarction","volume":"16","author":"Chen","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.3233\/CH-221380_ref61","first-page":"40","article-title":"Increased matrix metalloproteinase-9 activity in unstable carotid plaques","volume":"31","author":"Loftus","year":"2000","journal-title":"A potential role in acute plaque disruption. Stroke"},{"key":"10.3233\/CH-221380_ref62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-7120-9-24","article-title":"Videodensitometric analysis of advanced carotid plaque: Correlation with MMP-9 and TIMP-1 Expression","volume":"9","author":"Baroncini","year":"2011","journal-title":"Cardiovasc Ultrasound"},{"key":"10.3233\/CH-221380_ref63","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2796.2008.01927.x","article-title":"Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis","volume":"263","author":"Olson","year":"2008","journal-title":"J Intern Med"},{"key":"10.3233\/CH-221380_ref64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.CIR.0000133444.17867.56","article-title":"Established and emerging plasma biomarkers in the prediction of first atherothrombotic events","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"10.3233\/CH-221380_ref65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.ATV.0000256467.25384.c6","article-title":"Phagocytic NADPH Oxidase-dependent superoxide production stimulates matrix metalloproteinase-9","volume":"27","author":"Zalba","year":"2007","journal-title":"Implications for human atherosclerosis. Atheriosler Thromb Vasc Biol"},{"key":"10.3233\/CH-221380_ref66","first-page":"2583","article-title":"Matrix metalloproteases as a pharmacological target in cardiovascular diseases","volume":"19","author":"Hopps","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.3233\/CH-221380_ref67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000477785","article-title":"Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment","volume":"42","author":"Hopps","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"10.3233\/CH-221380_ref68","doi-asserted-by":"crossref","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","article-title":"Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals","volume":"11","author":"Er","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/CH-221380_ref69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.5551\/jat.47274","article-title":"Visceral adiposity index as an independent marker of subclinical atherosclerosis in individuals prone to diabetes mellitus","volume":"26","author":"Randrianarisoa","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.3233\/CH-221380_ref70","doi-asserted-by":"crossref","unstructured":"\u015at\u011bp\u0103nek L , Hor\u0103kov\u0103 D , Cibi\u010dkov\u0103 L\u2019 , Vaverkov\u0103 H , Kar\u0103sek D , Nakl\u0103dalov\u0103 M , et al. Can Visceral Adiposity Index serve as a simple tool for identifying individuals with insulin resistance in daily clinical practice? Medicina 2019;55:545.","DOI":"10.3390\/medicina55090545"},{"key":"10.3233\/CH-221380_ref71","doi-asserted-by":"crossref","first-page":"e000911","DOI":"10.1136\/bmjdrc-2019-000911","article-title":"Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage","volume":"7","author":"Fiorentino","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.3233\/CH-221380_ref72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12933-021-01391-7","article-title":"Gender difference in the association between TyG index and subclinical atherosclerosis: Results from the I-Lan Longitudinal Aging Study","volume":"20","author":"Lu","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.3233\/CH-221380_ref73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-021-01342-2","article-title":"Association between triglyceride-glucose index and risk of arterial stiffness: A cohort study","volume":"20","author":"Wu","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.3233\/CH-221380_ref75","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s41598-021-82053-2","article-title":"Lipid indices as simple and clinically useful surrogate markers for insulin resistance in the U.S. population","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"10.3233\/CH-221380_ref77","doi-asserted-by":"crossref","first-page":"614429","DOI":"10.3389\/fimmu.2021.614429","article-title":"Natural killer cells: Friend or foe in metabolic diseases?","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"10.3233\/CH-221380_ref78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00125-013-3080-0","article-title":"Differential wite cell count and incident type 2 diabetes: The insulin resistance atherosclerosis study","volume":"57","author":"Lorenzo","year":"2014","journal-title":"Diabetologia"},{"key":"10.3233\/CH-221380_ref79","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5152\/akd.2014.5787","article-title":"Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome?","volume":"15","author":"Bahadir","year":"2015","journal-title":"Anatol J Cardiology"},{"key":"10.3233\/CH-221380_ref80","first-page":"245","article-title":"The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity","volume":"49","author":"Karakaya","year":"2019","journal-title":"Turk J Med Sci"},{"key":"10.3233\/CH-221380_ref81","first-page":"43(e17537)","article-title":"Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"key":"10.3233\/CH-221380_ref82","doi-asserted-by":"crossref","first-page":"10036","DOI":"10.1038\/s41598-021-89494-9","article-title":"Comparison of the triglyceride glucose index and blood leukocyte indices as predictors of metabolic syndrome in health Chinese population","volume":"11","author":"Lin","year":"2021","journal-title":"Scientific Reports"},{"key":"10.3233\/CH-221380_ref83","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/DMSO.S219363","article-title":"Lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome","volume":"12","author":"Chen","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.3233\/CH-221380_ref84","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/DMSO.S238990","article-title":"Comparison of the value of neutrophil to high-density lipoprotein cholesterol ratio and lymphocyte to high-density lipoprotein cholesterol ratio for predicting metabolic syndrome among a population in the southern coast of China","volume":"13","author":"Chen","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.3233\/CH-221380_ref85","doi-asserted-by":"crossref","first-page":"Article 583320","DOI":"10.3389\/fcvm.2021.583320","article-title":"Lymphocyte to high-density lipoprotein ratio but not platelet to lymphocyte ratio effectively predicts metabolic syndrome among subjects from rural China","volume":"8","author":"Yu","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10.3233\/CH-221380_ref86","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1076029612459675","article-title":"Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome","volume":"20","author":"Buyukkaya","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.3233\/CH-221380_ref87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12902-015-0002-9","article-title":"Relationships between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients","volume":"5","author":"Lou","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.3233\/CH-221380_ref88","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/ATVBAHA.109.192583","article-title":"Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators","volume":"29","author":"Duffaut","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/CH-221380_ref89","doi-asserted-by":"crossref","first-page":"593058","DOI":"10.3389\/fimmu.2020.593058","article-title":"The adipocyte and adaptive immunity","volume":"11","author":"Song","year":"2020","journal-title":"Front Immunol"},{"key":"10.3233\/CH-221380_ref90","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.3390\/ijms221810017","article-title":"Crosstalk between metabolic disorders and immune cells","volume":"22","author":"Saitoh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.3233\/CH-221380_ref91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/CH-221380_ref92","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6793-12-4","article-title":"Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinases levels","volume":"12","author":"Tinahones","year":"2012","journal-title":"BMC Physiology"},{"key":"10.3233\/CH-221380_ref93","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1210\/jc.2009-2623","article-title":"Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone","volume":"95","author":"Unal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/CH-221380_ref94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.05.005","article-title":"Adipose extracellular matrix remodelling in obesity and insulin resistance","volume":"119","author":"Lin","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/CH-221380_ref95","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.3390\/ijms20194888","article-title":"Extracellular Matrix remodelling of adipose tissue in obesity and metabolic diseases","volume":"20","author":"Ruiz-Ojeda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.3233\/CH-221380_ref96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fphys.2019.00553","article-title":"Beneficial effect of bariatric surgery on abnormal MMP-9 and AMPK activities: potential markers of obesity-related CV risk","volume":"10","author":"Garcia-Prieto","year":"2019","journal-title":"Front Physiol"},{"key":"10.3233\/CH-221380_ref97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/cells8020158","article-title":"Behavior of metalloproteinases in adipose tissue, liver and arterial wall: An update of extracellular matrix remodeling","volume":"8","author":"Berg","year":"2019","journal-title":"Cells"},{"key":"10.3233\/CH-221380_ref98","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol."},{"key":"10.3233\/CH-221380_ref99","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.3233\/CH-221380_ref100","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1167\/iovs.17-22706","article-title":"Crosstalk between histone and DNA methylation in regulation of retinal matrix metalloproteinase-9 in diabetes","volume":"58","author":"Duraisamy","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.3233\/CH-221380_ref101","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/ijms18050905","article-title":"Matrix metalloproteinase gene activation resulting from disordered epigenetic mechanisms in rheumatoid arthritis","volume":"18","author":"Araki","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.3233\/CH-221380_ref102","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1097\/HJH.0b013e328364abd6","article-title":"Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure","volume":"31","author":"Mu\u00f1oz-Pacheco","year":"2013","journal-title":"J Hypertens"},{"key":"10.3233\/CH-221380_ref103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/07853890.2014.969303","article-title":"The effects of canrenone on inflammatory markers in patients with metabolic syndrome","volume":"47","author":"Derosa","year":"2015","journal-title":"Ann Med"},{"key":"10.3233\/CH-221380_ref104","first-page":"308","article-title":"Influence of spironolactone on matrix metalloproteinase-2 in acute decompensated heart failure","volume":"104","author":"Ferreira","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"10.3233\/CH-221380_ref105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.fjc.0000196241.96759.71","article-title":"Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension","volume":"47","author":"Martinez","year":"2006","journal-title":"Cardiovasc Pharmacol"},{"key":"10.3233\/CH-221380_ref106","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1291\/hypres.31.841","article-title":"Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency","volume":"31","author":"Nakamura","year":"2008","journal-title":"Hypertens Res"},{"key":"10.3233\/CH-221380_ref107","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/1074248413511692","article-title":"Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension","volume":"19","author":"Uzui","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"10.3233\/CH-221380_ref108","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12872-016-0237-z","article-title":"Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus","volume":"16","author":"Derosa","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.3233\/CH-221380_ref109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejphar.2008.04.031","article-title":"Inhibitory profiles of captopril on matrix metalloproteinase-9 activity","volume":"588","author":"Yamamoto","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/CH-221380_ref110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/hr.2010.205","article-title":"Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients","volume":"34","author":"Derosa","year":"2011","journal-title":"Hypertens Res."},{"key":"10.3233\/CH-221380_ref111","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10557-012-6420-2","article-title":"Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension","volume":"26","author":"Fontana","year":"2012","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.3233\/CH-221380_ref112","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2004.03.065","article-title":"Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease","volume":"44","author":"Schieffer","year":"2004","journal-title":"Am Coll Cardiol"},{"key":"10.3233\/CH-221380_ref113","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejim.2008.10.003","article-title":"Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment","volume":"20","author":"Onal","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.3233\/CH-221380_ref114","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5551\/jat.3624","article-title":"Blockade of renin-angiotensin system attenuates advanced glycation end products-mediated signaling pathways","volume":"17","author":"Kamioka","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.3233\/CH-221380_ref115","first-page":"454","article-title":"Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia","volume":"60","author":"Ercan","year":"2004","journal-title":"Kardiol Pol"},{"key":"10.3233\/CH-221380_ref116","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2003.09.007","article-title":"Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia","volume":"97","author":"Koh","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.3233\/CH-221380_ref117","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11095-008-9798-6","article-title":"Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia","volume":"26","author":"Qu","year":"2009","journal-title":"Pharm Res."},{"key":"10.3233\/CH-221380_ref118","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/biom10030359","article-title":"Expression of MMP-2, MMP-9, and NGAL in tissue and serum of patients with vascular aneurysms and their modulation by statin treatment: A pilot study","volume":"10","author":"Cione","year":"2020","journal-title":"Biomolecules"},{"key":"10.3233\/CH-221380_ref119","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000319072","article-title":"Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells","volume":"30","author":"Guo","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"10.3233\/CH-221380_ref120","doi-asserted-by":"crossref","first-page":"51707","DOI":"10.1371\/journal.pone.0051707","article-title":"Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One.e"},{"key":"10.3233\/CH-221380_ref121","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/iwj.12085","article-title":"Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease","volume":"12","author":"de Franciscis","year":"2015","journal-title":"Int Wound J"},{"key":"10.3233\/CH-221380_ref122","doi-asserted-by":"crossref","first-page":"9352015","DOI":"10.1155\/2017\/9352015","article-title":"MMP-2, MMP-9, and TIMP-4 and response to aspirin in diabetic and nondiabetic patients with stable coronary artery disease: A pilot study","volume":"2017","author":"Kuliczkowski","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.3233\/CH-221380_ref123","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1210\/jc.2009-2623","article-title":"Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone","volume":"95","author":"Unal","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/CH-221380_ref124","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3892\/mmr.2012.753","article-title":"Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells","volume":"5","author":"Esfahanian","year":"2012","journal-title":"Mol Med Rep"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CH-221380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:05:58Z","timestamp":1777388758000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CH-221380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":122,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/ch-221380","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]}}}